Biological and endocrinological insights into the possible breast cancer risk from menopausal estrogen replacement therapy
- 1 May 1993
- Vol. 58 (5) , 196-204
- https://doi.org/10.1016/0039-128x(93)90018-i
Abstract
No abstract availableKeywords
This publication has 103 references indexed in Scilit:
- The Risk of Breast Cancer after Estrogen and Estrogen–Progestin ReplacementNew England Journal of Medicine, 1989
- Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in DenmarkInternational Journal of Cancer, 1988
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- Breast Cancer in Mothers Given Diethylstilbestrol in PregnancyNew England Journal of Medicine, 1984
- Use of postmenopausal hormones and risk of myocardial infarction.Circulation, 1981
- Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement TherapyNew England Journal of Medicine, 1981
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- A Twenty-Five-Year Follow-up Study of Women Exposed to Diethylstilbestrol during PregnancyNew England Journal of Medicine, 1978
- Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics.BMJ, 1968